Stocktoria
Pluri Inc. PLUR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2007-12-10
Pluri Inc. statistics & valuation
Market cap$21.9M
P / S16.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 49.0% | 98.8% | 96.9% | 100.0% | — |
| Operating margin | -1659.9% | -6796.9% | -9493.4% | -17774.8% | — |
| Net margin | -1690.3% | -6407.4% | -9867.9% | -17624.8% | — |
| FCF margin | -1484.2% | -5627.0% | -8055.4% | -15718.4% | — |
| Return on assets | -58.4% | -52.8% | -55.8% | -60.6% | -53.3% |
| Return on equity | 330.1% | -385.7% | -185.1% | -128.1% | -87.3% |
| Current ratio | 0.68 | 6.98 | 7.37 | 8.46 | 5.85 |
| Revenue growth | 309.8% | 13.6% | 22.6% | — | — |
Source: SEC EDGAR filings · CIK 0001158780 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.